151 related articles for article (PubMed ID: 8054815)
1. The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury.
Isozaki H; Okajima K; Hara H; Kobayashi M
Surg Today; 1994; 24(5):435-40. PubMed ID: 8054815
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of thromboxane A2 activity during warm ischemia of the liver.
Shirabe K; Kin S; Shinagawa Y; Chen S; Payne WD; Sugimachi K
J Surg Res; 1996 Feb; 61(1):103-7. PubMed ID: 8769950
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model.
Garvin PJ; Niehoff ML; Robinson SM; Heisler T; Salinas-Madrigal L; Contis J; Solomon H
Transplantation; 1996 May; 61(10):1429-34. PubMed ID: 8633364
[TBL] [Abstract][Full Text] [Related]
4. The effects of thromboxane A2 synthetase inhibitor (OKY-046) on complete hepatic ischemia in rats with obstructive jaundice.
Takahashi T
Surg Today; 1996; 26(1):15-20. PubMed ID: 8680115
[TBL] [Abstract][Full Text] [Related]
5. Effects of thromboxane A2 synthesis inhibitor (OKY-046) on total liver ischemia in rats.
Kobayashi T; Esato K; Morita N; Noshima NS
Int Surg; 1996; 81(2):115-8. PubMed ID: 8912073
[TBL] [Abstract][Full Text] [Related]
6. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
[TBL] [Abstract][Full Text] [Related]
7. Involvement of thromboxane A2-thromboxane A2 receptor system of the hepatic sinusoid in pathogenesis of cold preservation/reperfusion injury in the rat liver graft.
Ishiguro S; Arii S; Monden K; Fujita S; Nakamura T; Niwano M; Harada T; Ushikubi F; Narumiya S; Imamura M
Transplantation; 1995 Apr; 59(7):957-61. PubMed ID: 7709455
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of dogs after 84% hepatectomy with emphasis on prostaglandin metabolites and the effect of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analog.
Iwata M
Surg Today; 1994; 24(12):1056-67. PubMed ID: 7780227
[TBL] [Abstract][Full Text] [Related]
9. Effect of thromboxane synthetase inhibitor on non-heart-beating donors in rat orthotopic liver transplantation.
Soejima Y; Yanaga K; Nisizaki T; Yoshizumi T; Uchiyama H; Sugimachi K
Surgery; 1998 Jan; 123(1):67-72. PubMed ID: 9457225
[TBL] [Abstract][Full Text] [Related]
10. Effects of a thromboxane synthetase inhibitor (OKY-046) in an ischemia-reperfusion model of intrauterine growth retardation in Sprague-Dawley rats.
Tanaka M; Natori M; Ishimoto H; Miyakoshi K; Miyazaki T; Kobayashi T; Yoshimura Y
Biol Neonate; 1997; 72(3):181-6. PubMed ID: 9303217
[TBL] [Abstract][Full Text] [Related]
11. The effect of cyclooxygenase-2 inhibitor FK3311 on ischemia-reperfusion injury in a canine total hepatic vascular exclusion model.
Sunose Y; Takeyoshi I; Ohwada S; Tsutsumi H; Iwazaki S; Kawata K; Kawashima Y; Tomizawa N; Matsumoto K; Morishita Y
J Am Coll Surg; 2001 Jan; 192(1):54-62. PubMed ID: 11192923
[TBL] [Abstract][Full Text] [Related]
12. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
Morimoto K; Ikata T; Tounai T
Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197
[TBL] [Abstract][Full Text] [Related]
13. Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on experimentally induced air embolism in anesthetized dogs.
Ishihara Y; Uchida Y; Kitamura S
Prostaglandins Leukot Med; 1986 Feb; 21(2):197-206. PubMed ID: 3457388
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of thromboxane A2 synthesis by OKY-046 attenuates ischemia and reperfusion injury of the liver.
Iida J; Shimamura T; Suzuki T; Jin MB; Taniguchi M; Fukai M; Yokota R; Horiuchi H; Magata S; Kishida A; Furukawa H; Todo S
Transplant Proc; 1999; 31(1-2):1061-2. PubMed ID: 10083474
[No Abstract] [Full Text] [Related]
15. Beneficial effect of donor pretreatment with thromboxane A2 synthase inhibitor on the graft survival in pig liver transplantation.
Yokoyama I; Negita M; Kobayashi T; Hayashi S; Hachisuka T; Sato E; Orihara A; Uchida K; Takagi H
J Surg Res; 1996 Jan; 60(1):232-8. PubMed ID: 8592420
[TBL] [Abstract][Full Text] [Related]
16. Effects of a selective thromboxane synthetase inhibitor (OKY-046) in patients with coronary artery disease during exercise.
Shikano M; Ito T; Ogawa K; Satake T
Jpn Heart J; 1987 Sep; 28(5):663-74. PubMed ID: 3323562
[TBL] [Abstract][Full Text] [Related]
17. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
[TBL] [Abstract][Full Text] [Related]
18. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels].
Baba H
Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic analysis of post-reperfusion syndrome and the effect of preventing this syndrome using thromboxane A2 synthetase inhibitor (OKY-046) in swine liver transplantation.
Ishine N; Yagi T; Ishikawa T; Sasaki H; Nakagawa K; Tanaka N
Transplant Proc; 1997; 29(1-2):378-81. PubMed ID: 9123045
[No Abstract] [Full Text] [Related]
20. Liberation of vasoactive substances and its prevention with thromboxane A2 synthase inhibitor in pig liver transplantation.
Yokoyama I; Kobayashi T; Negita M; Hayashi S; Yasutomi M; Katayama A; Uchida K; Takagi H
Transpl Int; 1996; 9(1):76-81. PubMed ID: 8748415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
